2. Industry Outlook
2.1. Market Definition
2.2. Porter's Five Forces Model
2.2.1. Threats of New Entrants
2.2.2. Threat of Substitute Products
2.2.3. Bargaining Power of Buyers
2.2.4. Bargaining Power of Suppliers
2.2.5. Competitive Rivalry
2.3. Covid-19 and Its Impact on Drug Discovery Market
2.4. PESTLE Outlook
2.5. Regulatory Framework
2.6. Value Chain Outlook
2.7. Market Attractiveness Index
2.8. Key Insight
2.9. Market Drivers
2.9.1. Growing Aged Population
2.9.2. Technological Advancements
2.9.3. Rise in Healthcare Expenditure
2.9.4. Surge in Lifestyle-Oriented Diseases
2.10. Market Restraints
2.10.1. Delay in Product Launches
2.10.2. Restricted Growth Rate Due to Generic Drugs
2.11. Market Opportunities
2.11.1. Significant Investment by Healthcare Industries in Improving Big Data Analytical Capabilities
2.11.2. Rising Demand for Specialty Medicines
2.12. Market Challenges
2.12.1. Poor Reimbursements Policies in Emerging Nations
2.12.2. Stringent Government Regulations
3. Drug Discovery Market Outlook - by Drug Type
3.1. Small Molecule Drug
3.2. Biologic Drug
4. Drug Discovery Market Outlook - by Technology
4.1. High Throughput Screening
4.2. Biochips
4.3. Bioinformatics
4.4. Pharmacogenomics and Pharmacogenetics
4.5. Combinatorial Chemistry
4.6. Nanotechnology
4.7. Spectroscopy
4.8. Metabolomics
4.9. Other Technologies
5. Drug Discovery Market Outlook - by Service
5.1. Drug Metabolism and Pharmacokinetics (Dmpk) Services
5.2. Chemical Services
5.3. Biological Services
5.4. Other Pharmaceutical Services
6. Drug Discovery Market Outlook - by End-User
6.1. Research Institutes
6.2. Pharmaceutical Companies
6.3. Contract Research Organizations (Cros)
6.4. Other End-Users
7. Drug Discovery Market – Latin America
7.1. Country Analysis
7.1.1. Brazil
7.1.2. Mexico
7.1.3. Rest of Latin America
8. Company Profiles
8.1. 3M Company
8.2. Abbott Laboratories Inc
8.3. Agilent Technologies Inc
8.4. Antares Pharma Inc
8.5. Astrazeneca plc
8.6. Bayer AG
8.7. Becton Dickinson & Company (Bd)
8.8. Boehringer Ingelheim
8.9. Eli Lily and Company
8.10. F Hoffmann-La Roche Ltd
8.11. GlaxoSmithKline LLC
8.12. Johnson & Johnson
8.13. Merck & Co Inc
8.14. Novartis
8.15. Pfizer Inc
8.16. Sanofi
9. Research Methodology & Scope
9.1. Research Scope & Deliverables
9.1.1. Objectives of Study
9.1.2. Scope of Study
9.2. Sources of Data
9.2.1. Primary Data Sources
9.2.2. Secondary Data Sources
9.3. Research Methodology
9.3.1. Evaluation of Proposed Market
9.3.2. Identification of Data Sources
9.3.3. Assessment of Market Determinants
9.3.4. Data Collection
9.3.5. Data Validation & Analysis
List of Tables
Table 1 Latin America Drug Discovery Market, by Country, 2019-2028 ($ Million)
Table 2 Latin America Drug Discovery Market, by Technology, 2019-2028 ($ Million)
Table 3 Latin America Drug Discovery Market, by Drug Type, 2019-2028 ($ Million)
Table 4 Latin America Drug Discovery Market, by Service, 2019-2028 ($ Million)
Table 5 Latin America Drug Discovery Market, by End-User, 2019-2028 ($ Million)
Table 6 Latin America Drug Discovery Market, by Country, 2019-2028 ($ Million)
List of Figures
Figure 1 Latin America Drug Discovery Market, by Region, 2019-2028 ($ Million)
Figure 2 Latin America Drug Discovery Market, by Small Molecule Drug, 2019-2028 ($ Million)
Figure 3 Latin America Drug Discovery Market, by Biologic Drug, 2019-2028 ($ Million)
Figure 4 Latin America Drug Discovery Market, by High Throughput Screening, 2019-2028 ($ Million)
Figure 5 Latin America Drug Discovery Market, by Biochips, 2019-2028 ($ Million)
Figure 6 Latin America Drug Discovery Market, by Bioinformatics, 2019-2028 ($ Million)
Figure 7 Latin America Drug Discovery Market, by Pharmacogenomics and Pharmacogenetics, 2019-2028 ($ Million)
Figure 8 Latin America Drug Discovery Market, by Combinatorial Chemistry, 2019-2028 ($ Million)
Figure 9 Latin America Drug Discovery Market, by Nanotechnology, 2019-2028 ($ Million)
Figure 10 Latin America Drug Discovery Market, by Spectroscopy, 2019-2028 ($ Million)
Figure 11 Latin America Drug Discovery Market, by Metabolomics, 2019-2028 ($ Million)
Figure 12 Latin America Drug Discovery Market, by Other Technologies, 2019-2028 ($ Million)
Figure 13 Latin America Drug Discovery Market, by Drug Metabolism and Pharmacokinetics (Dmpk) Services, 2019-2028 ($ Million)
Figure 14 Latin America Drug Discovery Market, by Chemical Services, 2019-2028 ($ Million)
Figure 15 Latin America Drug Discovery Market, by Biological Services, 2019-2028 ($ Million)
Figure 16 Latin America Drug Discovery Market, by Other Pharmaceutical Services, 2019-2028 ($ Million)
Figure 17 Latin America Drug Discovery Market, by Research Institutes, 2019-2028 ($ Million)
Figure 18 Latin America Drug Discovery Market, by Pharmaceutical Companies, 2019-2028 ($ Million)
Figure 19 Latin America Drug Discovery Market, by Contract Research Organizations (Cros), 2019-2028 ($ Million)
Figure 20 Latin America Drug Discovery Market, by Other End-Users, 2019-2028 ($ Million)
Figure 21 Brazil Drug Discovery Marke 2019-2028 ($ Million)
Figure 22 Mexico Drug Discovery Market 2019-2028 ($ Million)
Figure 23 Rest of Latin America Drug Discovery Market 2019-2028 ($ Million)
